Publication
The Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Center
| dc.contributor.author | Valente C | |
| dc.contributor.author | Figueira Vilela B | |
| dc.contributor.author | Paiva-Lopes MJ | |
| dc.contributor.author | Duarte B | |
| dc.date.accessioned | 2025-08-26T11:57:37Z | |
| dc.date.available | 2025-08-26T11:57:37Z | |
| dc.date.issued | 2025 | |
| dc.identifier.citation | Actas Dermosifiliogr. 2025 Jul-Aug;116(7):778-780 | |
| dc.identifier.doi | 10.1016/j.ad.2023.10.062 | |
| dc.identifier.uri | http://hdl.handle.net/10400.17/5144 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | Elsevier Espana | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Dupilumab | |
| dc.subject | Atopic Dermatitis | |
| dc.subject | HSAC DER | |
| dc.title | The Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Center | eng |
| dc.type | text | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 780 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 778 | |
| oaire.citation.volume | 116 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |